US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2024-08-15T00:00:00
Bortezomib for Injection in dosage form
Bortezomib for Injection, imported in 3.5 mg vials, is an antineoplastic agent. Bortezomib is a proteasome inhibitor indicated for the treatment of adult patients with multiple myeloma and mantle cell lymphoma
Description : Bortezomib for Injection in dosage form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :